DAIS ANALYTIC CORPORATION APPOINTS ELIZA WANG TO BOARD OF DIRECTORS
ODESSA, FL–(Marketwired – Apr 17, 2015) – Dais Analytic Corporation (OTCQB: DLYT), a commercial nanotechnology materials business selling its industry-changing technology into the worldwide energy and water markets, today announced the appointment of Eliza Xuan Wang to the company’s Board of Directors.
Ms. Wang has been the Managing Attorney of The Meridian Law, A Professional Law Corporation, since 2009. She is licensed to practice law in both California and New York, where she specializes in venture capital, general civil and commercial litigation, and immigration matters.
Ms. Wang has a Bachelor of Law degree from China University of Political Science and Law (Beijing, China) and an L.L.M. degree from Hastings College of The Law, University of California. Her experience in commercial and legal matters in both the United States and China is a significant asset to the Company as it seeks to further its business initiatives in China and other parts of Asia where green technologies are sorely needed, as highlighted by a recently completed Business Development Trade Mission through the Department of Commerce.
“I’m both thrilled and honored with the opportunity to join Dais Analytic at such an exciting time for the company,” said Ms. Wang. “The renewed emphasis on environmental footprint and sustainability around the globe provides an incredible opportunity for Dais, and I look forward to seeing our technology having a positive impact worldwide.”
“We’re pleased to have Eliza join our Board of Directors and look forward to her leadership and insights,” said Tim Tangredi, CEO, Dais Analytic Corporation. “Her experience in both the US and China is a terrific asset for us as we look to conduct further business in Asia, so her appointment could not have come at a more opportune time.”
About Dais Analytic Corporation
Dais Analytic Corporation (OTCQB: DLYT) is a nanotechnology business producing a versatile family of membrane materials — called Aqualyte — focusing on evolutionary or disruptive air, energy and water applications. The uses include:
- ConsERVâ„¢, a commercially available engineered energy recovery ventilator (an HVAC product) useful for efficient management of ventilation air’s temperature and moisture content using the energy found in the outgoing ‘stale’ air stream to pre-condition the incoming fresh air often saving energy, CO2, and allowing for equipment downsizing;
- NanoClearâ„¢, an early beta-stage method for treating contaminated water (notably most all forms of industrial waste), to provide pure drinking water;
- NanoAirâ„¢, an early beta-stage water-based, no fluorocarbon producing refrigerant cooling cycle useful to replace the existing gas based compression cooling cycle in most all forms of air-conditioning and refrigeration saving a projected 50% in energy and CO2;
- NanoCAPâ„¢, a prototype stage use of the Aqualyteâ„¢ family has shown itself to be a disruptive non-chemical energy-storage device which when completed will be useful in extending the value in renewable energy installations, transportation, consumer product uses, and ‘smart grid’ configurations.
Each use demonstrates the diversity of Dais’ core product — Aqualyteâ„¢ — the family of nano-structured polymers and engineered processes having a focus on minimizing consumption of irreplaceable natural resources, and ending the degradation of our environment. To find out more about Dais please visit https://daisanalytic.com, www.daischina.com, and to learn more about ConsERVâ„¢ please visit www.conserv.com.
Safe Harbor Statement
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. For example, statements about the future sales volume are forward looking and subject to risks. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Potential risks and uncertainties include, but are not limited to, risks outlined in the Company’s filings with the U.S. Securities and Exchange Commission. The Company does not undertake any obligation to update any forward-looking statement, except as required under applicable law.